Lung Cancer
Conference Coverage
Gene test may offer insights into treatment response in advanced NSCLC
Researchers linked positive assay results to longer progression-free survival.
Latest News
People with cancer should be wary of taking dietary supplements
Many patients still think over-the-counter vitamins, minerals, or herbal remedies will help.
Opinion
Oncologists may be too quick to refer patients to palliative care
Integrating palliative care into routine cancer care need not always require a specialty palliative care nurse.
News
FDA rejects poziotinib for certain types of lung cancer
The clinical data the company submitted was deemed insufficient for approval.
Conference Coverage
Lung cancer screening pushes 20-year survival rate to 80%
Less than 6% of high-risk smokers get the recommended annual lung cancer screening.
News
Durvalumab combinations show tentative promise in NSCLC
Phase 2 study indicates improved survival and objective response rate when combined with other immunotherapies.
Opinion
Had my patient come in today, we may have had other options
FDA’s approval of trastuzumab deruxtecan is a game-changer for NSCLC patients with HER alterations.
News
Despite benefits, extended-interval pembro uptake remains low
It’s possible that low uptake could stem from clinicians’ doubts about switching to an extended-interval dose, given that the FDA’s approval was...
Conference Coverage
Weight gain linked to cancer survival in men and women
The finding underscores the need for nutritional support emphasized in 2020 ASCO guidelines.
Latest News
Atezolizumab doubles survival of NSCLC patients with poor performance status
Patients typically excluded from clinical trials because of age or comorbidities had better survival with atezolizumab than single-agent...
